BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22370710)

  • 1. Patterns of BCR breakpoints in patients with coexisting inv(16)(p13.1q22) and t(9;22)(q34;q11.2).
    Bustamante D; Chan KR; Czuchlewski DR; Saadi AA
    Int J Hematol; 2012 Mar; 95(3):324-6. PubMed ID: 22370710
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
    Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
    Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors.
    Theil KS; Cotta CV
    Cancer Genet; 2014 May; 207(5):171-6. PubMed ID: 25027637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22).
    Tsuboi K; Komatsu H; Miwa H; Iida S; Banno S; Wakita A; Nitta M; Ueda R
    Leuk Res; 2002 Aug; 26(8):771-4. PubMed ID: 12191573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature.
    Colović M; Janković G; Bila J; Djordjević V; Wiernik PH
    Med Oncol; 1998 Sep; 15(3):199-201. PubMed ID: 9819797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.
    Rowe LR; Brothman AR; Nibley WE; Gaffney MR; Chen Z
    Cancer Genet Cytogenet; 2007 Apr; 174(1):54-6. PubMed ID: 17350467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of Inv(16)(p13q22) in a blast crisis of chronic myeloid leukemia: case report.
    Oñate G; Blanco ML; Pratcorona M
    Med Clin (Barc); 2019 May; 152(10):419-420. PubMed ID: 30392698
    [No Abstract]   [Full Text] [Related]  

  • 9. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia.
    Enright H; Weisdorf D; Peterson L; Rydell RE; Kaplan ME; Arthur DC
    Leukemia; 1992 May; 6(5):381-4. PubMed ID: 1593903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia.
    Heim S; Christensen BE; Fioretos T; Sørensen AG; Pedersen NT
    Cancer Genet Cytogenet; 1992 Mar; 59(1):35-8. PubMed ID: 1555189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
    Asou H; Eguchi M; Suzukawa K; Morishita K; Tanaka K; Date M; Hamamoto K; Kamada N
    Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
    Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
    J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR-ABL transcripts and t(10;11)(q11;p15).
    Xia T; Yang Y; Li G; Chang J; Li J; Ren F; Ren W; Wang H; Xu Z
    J Clin Lab Anal; 2020 Jun; 34(6):e23241. PubMed ID: 32052899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.